Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Role of osteoprotegerin in skeletal metabolism elucidated

Sep. 18, 1997

Separation of antiobesity and antidiabetic effects of beta3-adrenoceptor agonist established in rats

Sep. 18, 1997

Growth hormone antagonist enters phase II

Sep. 18, 1997

Duke University granted orphan drug status for Pompe's disease therapy

Sep. 17, 1997

Role of IL-1 receptors in osteoporosis elucidated

Sep. 17, 1997

Highlights from the Japanese Society of Bone Metabolism Research

Sep. 17, 1997

Fenfluramine, dexfenfluramine voluntarily withdrawn

Sep. 16, 1997

Hormone therapy vs. simvastatin for hypercholesterolemia in postmenopausal women

Sep. 15, 1997

Novartis evaluates SDZ-267-489 and analogues for increasing HDL cholesterol

Sep. 15, 1997

Potent GH secretagogues synthesized at Merck & Co.

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.